Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41467-020-14353-6
DC FieldValue
dc.titleYAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology
dc.contributor.authorTanaka, H.
dc.contributor.authorHomma, H.
dc.contributor.authorFujita, K.
dc.contributor.authorKondo, K.
dc.contributor.authorYamada, S.
dc.contributor.authorJin, X.
dc.contributor.authorWaragai, M.
dc.contributor.authorOhtomo, G.
dc.contributor.authorIwata, A.
dc.contributor.authorTagawa, K.
dc.contributor.authorAtsuta, N.
dc.contributor.authorKatsuno, M.
dc.contributor.authorTomita, N.
dc.contributor.authorFurukawa, K.
dc.contributor.authorSaito, Y.
dc.contributor.authorSaito, T.
dc.contributor.authorIchise, A.
dc.contributor.authorShibata, S.
dc.contributor.authorArai, H.
dc.contributor.authorSaido, T.
dc.contributor.authorSudol, M.
dc.contributor.authorMuramatsu, S.-I.
dc.contributor.authorOkano, H.
dc.contributor.authorMufson, E.J.
dc.contributor.authorSobue, G.
dc.contributor.authorMurayama, S.
dc.contributor.authorOkazawa, H.
dc.date.accessioned2021-08-23T03:17:08Z
dc.date.available2021-08-23T03:17:08Z
dc.date.issued2020-01-24
dc.identifier.citationTanaka, H., Homma, H., Fujita, K., Kondo, K., Yamada, S., Jin, X., Waragai, M., Ohtomo, G., Iwata, A., Tagawa, K., Atsuta, N., Katsuno, M., Tomita, N., Furukawa, K., Saito, Y., Saito, T., Ichise, A., Shibata, S., Arai, H., Saido, T., Sudol, M., Muramatsu, S.-I., Okano, H., Mufson, E.J., Sobue, G., Murayama, S., Okazawa, H. (2020-01-24). YAP-dependent necrosis occurs in early stages of Alzheimer’s disease and regulates mouse model pathology. Nature Communications 11 (1) : 507. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-020-14353-6
dc.identifier.issn20411723
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/198645
dc.description.abstractThe timing and characteristics of neuronal death in Alzheimer’s disease (AD) remain largely unknown. Here we examine AD mouse models with an original marker, myristoylated alanine-rich C-kinase substrate phosphorylated at serine 46 (pSer46-MARCKS), and reveal an increase of neuronal necrosis during pre-symptomatic phase and a subsequent decrease during symptomatic phase. Postmortem brains of mild cognitive impairment (MCI) rather than symptomatic AD patients reveal a remarkable increase of necrosis. In vivo imaging reveals instability of endoplasmic reticulum (ER) in mouse AD models and genome-edited human AD iPS cell-derived neurons. The level of nuclear Yes-associated protein (YAP) is remarkably decreased in such neurons under AD pathology due to the sequestration into cytoplasmic amyloid beta (Aβ) aggregates, supporting the feature of YAP-dependent necrosis. Suppression of early-stage neuronal death by AAV-YAPdeltaC reduces the later-stage extracellular Aβ burden and cognitive impairment, suggesting that preclinical/prodromal YAP-dependent neuronal necrosis represents a target for AD therapeutics. © 2020, The Author(s).
dc.publisherNature Research
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2020
dc.typeArticle
dc.contributor.departmentDEPT OF PHYSIOLOGY
dc.description.doi10.1038/s41467-020-14353-6
dc.description.sourcetitleNature Communications
dc.description.volume11
dc.description.issue1
dc.description.page507
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41467_020_14353_6.pdf8.4 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

27
checked on Sep 22, 2022

Page view(s)

88
checked on Sep 22, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons